Merck & Company (MRK)
99.00 x 1 100.00 x 4
Post-market by (Cboe BZX)
99.87 +0.42 (+0.42%) 12/26/24 [NYSE]
99.00 x 1 100.00 x 4
Post-market 99.75 -0.12 (-0.12%) 19:59 ET
for Thu, Dec 26th, 2024
Fiscal Year End Date: 12/31
03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
Sales | 15,901,000 | 13,521,000 | 13,154,000 | 11,402,000 | 10,627,000 |
Cost of Goods | 5,380,000 | 3,873,000 | 3,450,000 | 3,104,000 | 3,199,000 |
Gross Profit | 10,521,000 | 9,648,000 | 9,704,000 | 8,298,000 | 7,428,000 |
Operating Expenses | 4,899,000 | 5,897,000 | 4,781,000 | 6,602,000 | 4,599,000 |
Operating Income | 5,622,000 | 3,751,000 | 4,923,000 | 1,696,000 | 2,829,000 |
Other Income | -761,000 | 158,000 | 343,000 | 21,000 | 158,000 |
Pre-tax Income | 4,861,000 | 3,909,000 | 5,266,000 | 1,717,000 | 2,987,000 |
Income Tax | 554,000 | 85,000 | 695,000 | 503,000 | 238,000 |
Net Income Continuous | 4,307,000 | 3,824,000 | 4,571,000 | 1,214,000 | 2,749,000 |
Net Income Discontinuous | N/A | 372,000 | N/A | 332,000 | N/A |
Minority Interests | -3,000 | 438,000 | 4,000 | 1,000 | -430,000 |
Net Income | $4,310,000 | $3,758,000 | $4,567,000 | $1,545,000 | $3,179,000 |
EPS Basic Total Ops | 1.70 | 1.48 | 1.81 | 0.61 | 1.26 |
EPS Basic Continuous Ops | 1.70 | 1.51 | 1.81 | 0.48 | 1.08 |
EPS Basic Discontinuous Ops | N/A | -0.02 | N/A | 0.13 | 0.17 |
EPS Diluted Total Ops | 1.70 | 1.48 | 1.80 | 0.61 | 1.25 |
EPS Diluted Continuous Ops | 1.70 | 1.50 | 1.80 | 0.48 | 1.08 |
EPS Diluted Discontinuous Ops | N/A | -0.02 | N/A | 0.13 | 0.17 |
EBITDA(a) | $6,742,000 | $4,586,000 | $5,682,000 | $2,424,000 | $3,721,000 |